New schizophrenia drug aims to ease severe symptoms in hospitalized patients
NCT ID NCT06963034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug, NBI-1117568, to see if it improves schizophrenia symptoms like hallucinations and delusions better than a placebo. About 284 adults with schizophrenia who need hospital care will take the drug or a placebo for 5 weeks. The main goal is to measure symptom changes using a standard rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurocrine Clinical Site
RECRUITINGBryant, Arkansas, 72022, United States
-
Neurocrine Clinical Site
RECRUITINGLittle Rock, Arkansas, 72211, United States
-
Neurocrine Clinical Site
RECRUITINGAnaheim, California, 92805, United States
-
Neurocrine Clinical Site
RECRUITINGPico Rivera, California, 90660, United States
-
Neurocrine Clinical Site
RECRUITINGSan Diego, California, 92123, United States
-
Neurocrine Clinical Site
RECRUITINGSherman Oaks, California, 91403, United States
-
Neurocrine Clinical Site
RECRUITINGTorrance, California, 90504, United States
-
Neurocrine Clinical Site
RECRUITINGHollywood, Florida, 33024, United States
-
Neurocrine Clinical Site
RECRUITINGMiami Lakes, Florida, 33016, United States
-
Neurocrine Clinical Site
RECRUITINGAtlanta, Georgia, 30331, United States
-
Neurocrine Clinical Site
RECRUITINGDecatur, Georgia, 30030, United States
-
Neurocrine Clinical Site
RECRUITINGSnellville, Georgia, 30078, United States
-
Neurocrine Clinical Site
RECRUITINGChicago, Illinois, 60640, United States
-
Neurocrine Clinical Site
RECRUITINGGaithersburg, Maryland, 20877, United States
-
Neurocrine Clinical Site
RECRUITINGWatertown, Massachusetts, 02472, United States
-
Neurocrine Clinical Site
RECRUITINGMarlton, New Jersey, 08053, United States
-
Neurocrine Clinical Site
RECRUITINGStaten Island, New York, 10314, United States
-
Neurocrine Clinical Site
RECRUITINGThe Bronx, New York, 10461, United States
-
Neurocrine Clinical Site
RECRUITINGAustin, Texas, 78754, United States
-
Neurocrine Clinical Site
RECRUITINGDeSoto, Texas, 75115, United States
-
Neurocrine Clinical Site
RECRUITINGHouston, Texas, 77043, United States